SIST EN ISO 13004:2023

Overview

EN ISO 13004:2023 (adoption of ISO 13004:2022) specifies the VDmaxSD method for substantiating a selected radiation sterilization dose for health care products. It covers substantiation of fixed sterilization doses of 17.5, 20, 22.5, 27.5, 30, 32.5, or 35 kGy to achieve a sterility assurance level (SAL) of 10−6 or better. The standard also defines a sterilization dose audit procedure to demonstrate continued effectiveness of the substantiated dose and is used to meet sterilization dose requirements in ISO 11137-1.

Key Topics

• VDmaxSD method scope: Substantiation for selected discrete doses (listed above) to ensure SAL ≤ 10−6.
• Product family definition and maintenance: Rules for grouping products, designation of representative (master/equivalent/simulated) products, and record keeping.
• Sampling and testing: Guidance on sample selection, Sample Item Portion (SIP) concepts, microbiological testing and irradiation of test specimens.
• Bioburden determination: Frequency and procedures for measuring average bioburden as input to dose substantiation and audits.
• Verification dose experiments: Staged procedure (obtain samples → determine bioburden → select dose → obtain VD → perform verification experiments → interpret results) including confirmatory verification when required.
• Sterilization dose audit: Procedures and frequencies for periodic audits, pass/fail outcomes, and required corrective actions on failure.
• Supporting materials: Tables of SIP values and worked examples to aid application.

Applications

EN ISO 13004:2023 is intended for organizations involved in radiation sterilization of medical and health care products who need to substantiate and maintain a validated sterilization dose. Typical users:

• Medical device manufacturers and contract sterilization service providers
• Sterilization process engineers and microbiologists
• Quality assurance, regulatory and compliance professionals responsible for sterilization validation and process control
• R&D teams designing product families and test protocols

Practical benefits include a standardized, auditable approach to selecting fixed sterilization doses, clearer requirements for bioburden-based dose substantiation, and defined audit methods to maintain SAL targets across production.

Related Standards

• ISO 11137-1 - referenced for establishing sterilization dose within the process definition.
• EN ISO 13004:2023 supersedes CEN ISO/TS 13004:2014 and reflects ISO 13004:2022 content as adopted by CEN.

Keywords: EN ISO 13004:2023, ISO 13004:2022, VDmaxSD, radiation sterilization, sterilization dose, SAL 10−6, bioburden, sterilization dose audit, medical device sterilization.